BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Human epidermal growth factor receptor 2
1
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
7/15/2018 9:50:44 AM | Browse: 25 | Download: 4
2
Targeted therapies in breast cancer: New challenges to fight against resistance
4/7/2017 8:24:12 AM | Browse: 153 | Download: 207
3
Recent developments and innovations in gastric cancer
4/29/2016 4:50:00 PM | Browse: 281 | Download: 541
4
Companion diagnostics for the targeted therapy of gastric cancer
12/10/2015 10:17:00 AM | Browse: 225 | Download: 369
5
Human epidermal growth factor receptor 2 amplification and protein expression in mixed gastric carcinoma
4/30/2015 2:11:00 PM | Browse: 190 | Download: 461
6
Recent advances in the HER2 targeted therapy of gastric cancer
1/14/2015 10:56:00 AM | Browse: 336 | Download: 297
7
Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?
12/12/2014 11:15:00 AM | Browse: 284 | Download: 474
8
Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer
9/16/2014 1:19:00 PM | Browse: 271 | Download: 164
9
HER2 therapies and gastric cancer: A step forward
9/12/2014 8:40:00 PM | Browse: 165 | Download: 218
10
Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies
9/12/2014 8:40:00 PM | Browse: 166 | Download: 203
11
Death decoy receptor overexpression and increased malignancy risk in colorectal cancer
8/29/2014 11:31:00 AM | Browse: 221 | Download: 245
12
Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects
8/28/2014 5:50:00 PM | Browse: 301 | Download: 187
Write to the Help Desk
© 2004-2017 Baishideng Publishing Group Inc. All rights reserved. 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA

California Corporate Number: 3537345